Molecular diagnostics are specialized tests doctors use to look at proteins, RNA, and DNA in and on cancer cells. When you have breast cancer, they show your doctors what’s unique about your tumor so ...

Faster Test Results for Infection Lead to Safer and More Cost-Effective Hospitals The process of culture-based testing for microbes has been in common use for more than a century. In recent decades, ...

Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.

Over the past few months, the Molecular Diagnostics market has been prospering well on the back of the COVID-19 havoc, followed by the surge in Monkeypox cases. Apart from these instances, the niche ...

Minute Molecular Diagnostics, a biotech spinout from Northwestern University that says it’s created rapid PCR COVID-19 tests, has received emergency use authorization for its product from the U.S.

Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...

REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...

The MiniDock MTB could expand access to molecular testing in peripheral health centers ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it ...

Manila HealthTek Inc. (MTek) and Unsilo Labs Inc. (Unsilo) have signed a Memorandum of Agreement to co-develop Lab-in-a-Mug 3 ...